Neurent Medical has closed an oversubscribed Series C financing round, raising €62.5m ($74m) to expand commercial activities ...

Neurent Medical announced today that it raised $74 million (€62.5 million) in an oversubscribed Series C financing round.

BOSTON & LONDON--(BUSINESS WIRE)--MVM Partners today announced the closing of a $325 million healthcare fund, MVM V. MVM has been investing in high growth healthcare businesses since 1997 and this ...

IRVINE, CA, and HERSTAL, BELGIUM – 27 April 2020 – MDxHealth SA (Euronext Brussels: MDXH) (the "Company" or "MDxHealth") a commercial-stage innovative molecular diagnostics company, announces today ...

These transactions reflect MVM Partners' ongoing management of its investment in Paragon 28, a company specializing in surgical and medical instruments. In other recent news, Paragon 28, a key player ...

LONDON & BOSTON--(BUSINESS WIRE)--MVM Life Science Partners today announced the closing of a $233 million healthcare fund, MVM IV. The fund is MVM’s fourth and largest raised to date. MVM IV is ...

Since receiving FDA clearance in 2019, many designated US cancer centers have adopted icotec's BlackArmor® products. This investment will enable icotec to continue its impressive growth and strengthen ...

Following these transactions, MVM Partners now holds 8,854,883 shares of Paragon 28, which has a market capitalization of $1.09 billion. The shares were sold in multiple transactions, and the prices ...

MVM Life Science Partners today announced the closing of a $233 million healthcare fund, MVM IV. The fund is MVM’s fourth and largest raised to date. MVM IV is investing in medical companies, ...